The Column Group II, LP 13D and 13G filings for eFFECTOR Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-22 4:16 pm Sale |
2023-11-15 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
The Column Group II, LP | 0 0.000% |
-163,669 (Position Closed) |
Filing |
| 2023-09-15 4:05 pm Sale |
2023-06-15 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
The Column Group II, LP | 163,669 6.600% |
-8,704 (-5.05%) |
Filing |
| 2021-09-07 5:12 pm Purchase |
2021-08-25 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
The Column Group II, LP | 172,373 10.600% |
172,373 (New Position) |
Filing |